Showing results (51-60 of 10,495) with videos related to
Sort By:
Pageof 1,050
Nature Reviews. Clinical Oncology|April 26, 2022
Optimal systemic therapy for high-risk resectable melanomaAlexander M M Eggermont, Omid Hamid, Georgia V Long, et al.Experimental Dermatology|January 17, 2021
Genetic drivers of non-cutaneous melanomas: Challenges and opportunities in a heterogeneous landscapeIsmael A Vergara, James S Wilmott, Georgina V Long, et al.Lancet (London, England)|April 19, 2026
Targeting MEK in cancer and beyond: mechanistic insights and therapeutic opportunitiesWei Yen Chan, Ines Pires da Silva, Georgina V Long, et al.Nature Reviews. Clinical Oncology|July 24, 2023
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitorsRebecca C Simpson, Erin R Shanahan, Richard A Scolyer, et al.European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapyFlorentia Dimitriou, Sabrina Hogan, Alexander M Menzies, et al.Anti-Cancer Drug Design|October 6, 1997
Interaction of the antitumour antibiotic streptonigrin with DNA and oligonucleotidesG V Long, M M Harding, J Y Fan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2017
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic MelanomaTuba N Gide, James S Wilmott, Richard A Scolyer, et al.The British Journal of Surgery|January 18, 2018
Impact of genomics on the surgical management of melanomaP M Ferguson, G V Long, R A Scolyer, et al.Journal of Elder Abuse & Neglect|May 1, 2014
Elder abuse and neglect: a survey of Irish general practitionersJames G O'Brien, Ailis Ni Riain, Claire Collins, et al.Pathology|January 20, 2024
Prognostic and predictive biomarkers in melanomaNigel G Maher, Ismael A Vergara, Georgina V Long, et al.Pageof 1,050